<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250524065874N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-08-07</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Effects of Group Therapy on Patients with Parkinson's Disease</public_title>
      <acronym></acronym>
      <scientific_title>Investigating Emotional, Cognitive, and Motor Planning Status Following Group Rehabilitation Therapy in Individuals with Parkinson's Disease: A Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/83782</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization Method:
Participants who meet the inclusion criteria and provide informed consent will be randomly assigned in a 1:1 ratio to one of two groups: the intervention group (Group A) or the control group (Group B).

Type and Unit of Randomization:
In this study, block randomization with variable block sizes will be used to maintain balance in the number of participants in each group throughout the study. The unit of randomization is the individual participant.

Block Size:
Block sizes will be variable, consisting of blocks of 4 and 6 participants. This method helps to prevent prediction of the allocation sequence.

Stratified Randomization:
To ensure balance between groups regarding key variables, stratified randomization will be performed. The strata will be defined based on the following two main variables:

Disease severity (according to the Hoehn and Yahr scale),

Age group (less than 60 years, and 60 years or older)

Generation of Random Sequence:
The random sequence will be generated using Microsoft Excel and the RAND function. Separate sequences will be created for each stratum and then arranged into variable-sized blocks.

Allocation Concealment:
The allocation of participants to groups will be performed by an independent researcher who is not involved in recruitment, assessment, or intervention of participants. The randomization sequences will be kept in sealed and numbered envelopes. After each participant is enrolled, the researcher responsible for allocation will open the envelope corresponding to the next sequence to determine the assigned group. This method ensures that group allocation remains concealed from both the researcher and the participant until the appropriate time, thereby preventing selection bias, Blinding description: In this study, a double-blind design will be implemented to reduce bias and increase the validity of the results; this means that both the outcome assessors and the data analysts will be blinded to the allocation of participants to the intervention and control groups.

Participants will be fully informed of the group to which they are assigned; however, to prevent expectation bias, detailed and specific information about the differences between the interventions will not be provided, and only general explanations regarding the study’s purpose and the type of interventions will be given. This approach is conducted in accordance with ethical principles and respect for participants' right to be informed.

Assessors who measure emotional status, cognitive function, and motor planning will operate independently and will have no access to group allocation information. Additionally, therapists delivering the interventions will not be involved in outcome assessment or data analysis.

Data analysts will also conduct statistical analyses blinded to group allocation to prevent bias.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Parkinson's disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group (1): The treatment is designed based on the group rehabilitation approach and the framework of the Model of Human Occupation (MOHO). MOHO emphasizes the interaction of three core systems of the individual—volition, habituation, and performance capacity—within the environment, aiming to enhance the cognitive, motivational, and motor abilities of the participants. This treatment is delivered as structured and regular group therapy sessions which, in addition to improving individual skills, strengthen social support, increase positive group interactions, and enhance participants' motivation for active engagement in the therapeutic process. The therapeutic methods implemented in the sessions include cognitive exercises such as problem-solving, decision-making, and enhancing attention and focus, using cognitive training tools like memory cards, logical puzzles, and brain games. Motivational exercises incorporate intrinsic motivation enhancement techniques based on the MOHO model, including identifying individual goals and strengthening volition and enthusiasm for activity engagement. Motor and skill exercises involve hand-eye coordination, balance training, and practicing motor skills with the use of therapy balls, simple balance devices such as balance boards and soft cushions, and mild motor aids like hoops and soft ropes. The group therapy also includes group sports programs executed as coordinated collective activities; these sports involve balance exercises, mild strength activities, coordinated hand-eye movements, and simple team activities designed for levels 1 to 3 of Hoehn and Yahr, representing various ability levels from basic to intermediate. Group sports, tailored to participants’ interests and motor capabilities, help promote social participation, increase motivation, and improve physical health. At the end of each session, participants have the opportunity for discussion, performance evaluation, and receiving feedback from the therapist, which promotes ongoing enhancement of individual and group motivation and performance. Between sessions, motivational activities and assignments are specified to help maintain practice in the participants’ daily environments and to support continuity of treatment progress. The equipment used includes cognitive tools such as memory cards with various images and words, multistage logical puzzles, and brain games. Motor equipment consists of therapy balls for motor exercises, simple balance tools like balance boards and special cushions, hoops, and soft ropes for group motor coordination practice. The venue is a rehabilitation room equipped with proper lighting, ventilation, and ample open space suitable for conducting group exercises and collective sports. The total course involves 12 sessions held over four weeks with a schedule of three sessions per week, each lasting 60 minutes. The duration and number of sessions are adjustable based on feedback from a pilot study and expert opinions. The treatment is completely non-pharmacological; no chemical substances, drugs, formulations, or dosages are used in the interventions. The treatment cumulatively includes cognitive, motivational, motor, and group sports activities. Group sports are especially suitable for Hoehn and Yahr levels one to three, which correspond to graded motor and cognitive abilities, and are designed and executed according to the participants' interests and motivation. After the pilot study is completed and experts’ feedback collected, detailed protocols for each session and the equipment used will be fully documented and finalized. Intervention 2: Control Group (2):The control group will receive a conventional rehabilitation program based on standardized protocols from previous studies.                                                                                                                 Treatment Method: Conventional rehabilitation exercises including muscle stretching, strengthening exercises, and endurance activities, which differ from the cognitive-motivational approach of the intervention group. Equipment Used: Standard rehabilitation equipment such as therapy balls, resistance bands, light dumbbells, and basic muscle training tools. Number and Duration of Sessions: Equivalent to the intervention group; 12 sessions over 4 weeks (each session lasting 60 minutes).                       Session Content: Body warm-up and specific stretching exercises Muscle strengthening exercises tailored to the participants' conditions Endurance training (such as walking on a treadmill or using a stationary bicycle)Basic balance and coordination exercises.                                                    Intervention Period:4 weeks (concurrent with the intervention group).Other Details: All exercises will be taught and supervised by trained occupational therapists and physiotherapists, with safety principles ensured throughout.                                                                                      Note: No medications, chemical compounds, or specific supplements are used in this study, and the focus in both groups is on non-pharmacological, functional rehabilitation interventions. Should further details be required (such as a precise session schedule or information on specific equipment), additional information will be provided following the completion of the pilot study and review by the expert panel.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is not decided</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zeinab Fathipour-Azar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Rehabilitation Sciences, Next to Vahdat Hall, University of Tabriz, 29 Bahman Boulevard, Tabriz, Iran</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166616471</zip>
        <telephone>+98 41 3337 5359</telephone>
        <email>fathipourz@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zeinab Fathipour-Azar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Rehabilitation Sciences, Next to Vahdat Hall, University of Tabriz, 29 Bahman Boulevard, Tabriz, Iran</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166616471</zip>
        <telephone>+98 41 3337 5359</telephone>
        <email>fathipourz@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>•Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist, based on established criteria such as the UK Brain Bank
Disease severity at stages 1 to 3 according to the Hoehn and Yahr scale
Age range approximately between 30  to 80  years old
Adequate cognitive function, typically defined by a score of 24 or higher on the Mini Mental State Examination (MMSE) or Montreal Cognitive Assessment (MoCA)
Ability to perform motor tasks relevant to the intervention, including uni-manual and bi-manual activities of daily living
Minimum educational level to ensure comprehension and participation in therapy
Willingness and ability to provide informed consent and participate actively in group therapy sessions
Having a stable medication regimen for Parkinson's disease symptoms for at least two months prior to enrollment in the study</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Significant psychiatric disorders such as major depression, psychosis, or severe anxiety that may interfere with participation
Other neurological or musculoskeletal conditions that significantly affect motor function (e.g., stroke, severe arthritis)
Participation in other clinical trials or rehabilitation programs that could confound results
Severe sensory impairments (e.g., vision or hearing loss) that limit ability to engage in therapy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Hemiparkinsonism Paralysis agitans Parkinsonism or Parkinson disease: NOSidiopathicprimary</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group (1): The treatment is designed based on the group rehabilitation approach and the framework of the Model of Human Occupation (MOHO). MOHO emphasizes the interaction of three core systems of the individual—volition, habituation, and performance capacity—within the environment, aiming to enhance the cognitive, motivational, and motor abilities of the participants. This treatment is delivered as structured and regular group therapy sessions which, in addition to improving individual skills, strengthen social support, increase positive group interactions, and enhance participants' motivation for active engagement in the therapeutic process. The therapeutic methods implemented in the sessions include cognitive exercises such as problem-solving, decision-making, and enhancing attention and focus, using cognitive training tools like memory cards, logical puzzles, and brain games. Motivational exercises incorporate intrinsic motivation enhancement techniques based on the MOHO model, including identifying individual goals and strengthening volition and enthusiasm for activity engagement. Motor and skill exercises involve hand-eye coordination, balance training, and practicing motor skills with the use of therapy balls, simple balance devices such as balance boards and soft cushions, and mild motor aids like hoops and soft ropes. The group therapy also includes group sports programs executed as coordinated collective activities; these sports involve balance exercises, mild strength activities, coordinated hand-eye movements, and simple team activities designed for levels 1 to 3 of Hoehn and Yahr, representing various ability levels from basic to intermediate. Group sports, tailored to participants’ interests and motor capabilities, help promote social participation, increase motivation, and improve physical health. At the end of each session, participants have the opportunity for discussion, performance evaluation, and receiving feedback from the therapist, which promotes ongoing enhancement of individual and group motivation and performance. Between sessions, motivational activities and assignments are specified to help maintain practice in the participants’ daily environments and to support continuity of treatment progress. The equipment used includes cognitive tools such as memory cards with various images and words, multistage logical puzzles, and brain games. Motor equipment consists of therapy balls for motor exercises, simple balance tools like balance boards and special cushions, hoops, and soft ropes for group motor coordination practice. The venue is a rehabilitation room equipped with proper lighting, ventilation, and ample open space suitable for conducting group exercises and collective sports. The total course involves 12 sessions held over four weeks with a schedule of three sessions per week, each lasting 60 minutes. The duration and number of sessions are adjustable based on feedback from a pilot study and expert opinions. The treatment is completely non-pharmacological; no chemical substances, drugs, formulations, or dosages are used in the interventions. The treatment cumulatively includes cognitive, motivational, motor, and group sports activities. Group sports are especially suitable for Hoehn and Yahr levels one to three, which correspond to graded motor and cognitive abilities, and are designed and executed according to the participants' interests and motivation. After the pilot study is completed and experts’ feedback collected, detailed protocols for each session and the equipment used will be fully documented and finalized.</i_keyword>
      <i_keyword>Control Group (2):The control group will receive a conventional rehabilitation program based on standardized protocols from previous studies.                                                                                                                 Treatment Method: Conventional rehabilitation exercises including muscle stretching, strengthening exercises, and endurance activities, which differ from the cognitive-motivational approach of the intervention group. Equipment Used: Standard rehabilitation equipment such as therapy balls, resistance bands, light dumbbells, and basic muscle training tools. Number and Duration of Sessions: Equivalent to the intervention group; 12 sessions over 4 weeks (each session lasting 60 minutes).                       Session Content: Body warm-up and specific stretching exercises Muscle strengthening exercises tailored to the participants' conditions Endurance training (such as walking on a treadmill or using a stationary bicycle)Basic balance and coordination exercises.                                                    Intervention Period:4 weeks (concurrent with the intervention group).Other Details: All exercises will be taught and supervised by trained occupational therapists and physiotherapists, with safety principles ensured throughout.                                                                                      Note: No medications, chemical compounds, or specific supplements are used in this study, and the focus in both groups is on non-pharmacological, functional rehabilitation interventions. Should further details be required (such as a precise session schedule or information on specific equipment), additional information will be provided following the completion of the pilot study and review by the expert panel.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Emotional status. Timepoint: Before the start of the intervention, 4 weeks after the intervention, 4 weeks after the completion of the intervention. Method of measurement: The emotional status is assessed using the Hospital Anxiety and Depression Scale (HADS) and the Beck Depression Inventory (BDI).</prim_outcome>
      <prim_outcome>Cognitive function. Timepoint: Before the start of the intervention, 4 weeks after the intervention, 4 weeks after the completion of the intervention. Method of measurement: Cognitive function is evaluated with the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination (MMSE).</prim_outcome>
      <prim_outcome>Motor function. Timepoint: Before the start of the intervention, 4 weeks after the intervention, 4 weeks after the completion of the intervention. Method of measurement: Motor planning and performance are measured by Part III of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS Part III) and the Purdue Pegboard Test. Additionally, a motion analysis system may be used for more precise quantitative assessment of motor function.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Participation in activity of daily living (ADL). Timepoint: Before the start of the intervention, 4 weeks after the intervention, 4 weeks after the completion of the intervention. Method of measurement: The Canadian Occupational Performance Measure (COPM) for evaluating patient's participation in Activities of daily living.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-05-12</approval_date>
        <contact_name>Ethics committee of Tabriz university of Medical Science</contact_name>
        <contact_address>Third Floor, Deputy of Research and Technology, Central Building No. 2, Tabriz University of Medical Sciences, Golgasht Street, Tabriz Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
